| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |